- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Serum aldosterone independent predictor of HFpEF prognosis: Study
China: The level of serum aldosterone is independently associated with all-cause mortality and primary endpoint in heart failure with a preserved ejection fraction (HFpEF) patients, a recent study has revealed.
The results of the research, published in the journal Science China Life Sciences, indicate that aldosterone is an independent predictor of HFpEF prognosis.
Currently, patients with HFpEF have a high risk of morbidity and mortality, but there is no effective measure for evaluating the prognosis. Studies have found that a variety of ways can lead to the development of HFpEF, including neurohormones or heart damage. Especially, aldosterone plays an important role in the development of heart failure. The renin-angiotensin-aldosterone system is activated, which stimulates aldosterone secretion from the adrenal cortex. Elevated aldosterone is associated with myocardial hypertrophy and fibrosis, leading to arterial stiffness, cardiac dysfunction, and risk of morbidity and mortality in heart failure.
In the above context, Lijia Jia, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China, and colleagues assessed the association of serum aldosterone level with all-cause mortality and HF-hospitalization for patients with HFpEF.
"We demonstrate that level of serum aldosterone is independently associated with all-cause mortality (adjusted hazard ratio (aHR), 1.55) and primary endpoint (aHR, 1.43) in HFpEF.," said Dr. Bingbing Ke, the first author for this work. The results of this research indicate that aldosterone is an independent predictor of HFpEF prognosis. "The higher aldosterone level is associated with more risk of concentric left ventricular remodeling (adjusted odds ratio (aOR), 1.45), and poor prognosis. Moreover, patients with high aldosterone and BNP concentrations were at a higher risk of the primary endpoint (hazard ratio (HR), 1.85)," said Professor Jie Du, the co-corresponding author. Serum aldosterone concentrations provide a new measure for risk evaluation of all-cause mortality and HF re-hospitalization in HFpEF patients. Measurement of serum aldosterone concentration provides additive prognostic value when combined with BNP.
Reference:
The study titled, "Nanopore sequencing of African swine fever virus," is published in the journal Science China Life Sciences.
https://www.sciengine.com/publisher/scp/journal/SCLS/63/1/10.1007/s11427-019-9828-1
Hina Zahid Joined Medical Dialogue in 2017 with a passion to work as a Reporter. She coordinates with various national and international journals and association and covers all the stories related to Medical guidelines, Medical Journals, rare medical surgeries as well as all the updates in the medical field. Email:Â editorial@medicaldialogues.in. Contact no. 011-43720751
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751